Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001193125-25-288632 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-11-19 | 2025-11-17 | FDMT | Bizily Scott | CLO | M - OptEx | $4.14 | +1,635 | 5,229 | +45% | +$6,769 |
| DT | 2025-11-19 | 2025-11-17 | FDMT | Bizily Scott | CLO | S - Sale+OE | $10.59 | -1,635 | 3,594 | -31% | -$17.3K |
| DT | 2025-11-19 | 2025-11-17 | FDMT | Bizily Scott | CLO | M - OptEx | $0.00 | -1,635 | 75.2K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | M | A | 1,635 | $4.14 | 5,229 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-17 | S | D | 1,635 | $10.59 | 3,594 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-11-17 | M | D | 1,635 | $0.00 | 75,230 | D | $4.14 · — to 2035-03-05 | 1,635 Common Stock | (F2) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |